TMDX COURT ALERT: BFA Law Alerts TransMedics Group, Inc. Investors with Losses to Contact the Firm about Pending Securities Fraud Class Action
New York, New York-- (Newsfile Corp. - March 14, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX) ...
Apple’s cool Major League Soccer logo mash-ups are changing the rules of co-branding
Brand collabs often a similar pattern. So it’s remarkable to see Apple modify its logo for each of the 30 Major League Soccer ...
TMDX SHAREHOLDER NOTICE: TransMedics Group, Inc. Investors are Reminded to Contact BFA Law before the April 15 Class Action Deadline
New York, New York-- (Newsfile Corp. - March 13, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX) ...
Insurance Asia on MSN5d
BMS CEO’s key to success is communication
Asking for support shows self-awareness and commitment to growth. Sandra Lee, Asia CEO at London-based insurer BMS Group Ltd.
DelveInsight Business Research, LLP: BREYANZI Demonstrates Continued Growth in the Competitive CAR-T Market | DelveInsight
BREYANZI has significant market potential due to its innovative approach as a CD19-directed chimeric antigen receptor (CAR) T-cell therapy. The growing prevalence of hematologic malignancies ...
BREYANZI Demonstrates Continued Growth in the Competitive CAR-T Market | DelveInsight
DelveInsight's 'BREYANZI Market Size, Forecast, and Market Insight Report' highlights the details around BREYANZI, a CD19-directed CAR ...